Aprovel

Italy
Brand name Aprovel
Form tablets
Active substance / Dosage
Prescription type Prescription only
ATC code
Registration number 033264
Aprovel tablets

Table of Contents

Package leaflet: Information for the patient

Aprovel 75 mg tablets

irbesartan
Please read this leaflet carefully before taking this medicine because it contains
important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not give it to others. It may be harmful to other people, even if their symptoms are the same as yours.
  • If you experience any side effect, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.

Contents of this leaflet:

  1. What Aprovel is and what it is used for
  2. What you need to know before taking Aprovel
  3. How to take Aprovel
  4. Possible side effects
  5. How to store Aprovel
  6. Contents of the pack and other information

1. What Aprovel is and what it is used for

Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced by the body that binds to receptors in blood vessels, causing them to constrict. This results in an increase in blood pressure. Aprovel prevents angiotensin-II from binding to these receptors, allowing blood vessels to dilate and blood pressure to decrease. Aprovel slows the decline in renal function in patients with high blood pressure and type 2 diabetes.
Aprovel is used in adult patients

  • to treat high blood pressure ( essential hypertension )
  • to protect the kidneys in hypertensive patients with high blood pressure, type 2 diabetes, and evidence of kidney dysfunction shown by laboratory tests.

2. What you need to know before taking Aprovel

Do not take Aprovel:

    • if you are allergic to irbesartan or to any of the other ingredients of this medicine (listed in section 6)
  • if you are more than 3 months pregnant (it is better to avoid taking Aprovel even in the early stages of pregnancy - see section Pregnancy)
  • if you have diabetes or impaired kidney function and are being treated with a blood pressure-lowering medicine containing aliskiren

Warnings and precautions
Talk to your doctor before taking Aprovel if you are in any of the following conditions:

  • excessive vomiting or diarrhoea
  • if you have kidney disorders
  • if you have heart problems
  • if you are taking Aprovel for diabetic kidney disease. In this case, your doctor may prescribe regular blood tests, especially to monitor serum potassium levels in case of poor kidney function
  • if you develop low blood sugar levels (symptoms may include sweating, weakness, hunger, dizziness, trembling, headache, flushing or paleness, numbness, rapid and pounding heartbeat), especially if you are being treated for diabetes
  • if you are scheduled for surgery or taking anaesthetics
  • if you are taking any of the following medicines used to treat high blood pressure:
  • an "ACE inhibitor" (e.g., enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes
  • aliskiren

Your doctor may check your kidney function, blood pressure, and the amount of electrolytes
(e.g., potassium) in your blood at regular intervals.
See also the information under the heading "Do not take Aprovel".
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming
pregnant). Aprovel is not recommended during early pregnancy and must not be taken after the first
3 months of pregnancy, as it may cause serious harm to the unborn baby if taken during this period (see section Pregnancy).
Children and adolescents
This medicine must not be used in children and adolescents, as its safety and efficacy have not yet been fully established.
Other medicines and Aprovel
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor may consider it necessary to adjust your dose and/or take other precautions:
If you are taking an ACE inhibitor or aliskiren (see also the sections "Do not take Aprovel" and "Warnings and precautions").
You may need blood tests if you are taking:

  • potassium supplements
  • potassium-containing salt substitutes
  • potassium-sparing medicines (such as certain diuretics)
  • medicines containing lithium
  • repaglinide (a medicine used to lower blood sugar levels)

If you take certain painkillers called non-steroidal anti-inflammatory drugs (NSAIDs), the effectiveness of irbesartan may be reduced.
Aprovel with food and drink
Aprovel can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming pregnant). Your doctor will usually advise you to stop taking Aprovel before becoming pregnant or as soon as pregnancy is confirmed, and will recommend an alternative medicine. Aprovel is not recommended during early pregnancy and must not be taken after the first 3 months of pregnancy, as it may cause serious harm to the unborn baby if taken beyond the third month of pregnancy.
Breast-feeding
Inform your doctor if you are breast-feeding or about to start breast-feeding. Aprovel is not recommended for women who are breast-feeding, and your doctor may choose an alternative treatment if you wish to breast-feed, especially if the baby is a newborn or was born prematurely.
Driving and using machines
It is unlikely that Aprovel will affect your ability to drive or use machines. However, occasionally, dizziness or fatigue may occur during treatment for high blood pressure. If this happens, talk to your doctor before driving or operating machinery.
Aprovel contains lactose. If your doctor has diagnosed you with an intolerance to certain sugars, contact him before taking this medicine.
Aprovel contains sodium. This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e., it is essentially 'sodium-free'.

3. How to take Aprovel

Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Method of administration
Aprovel is for oral use. Swallow the tablets with a sufficient amount of fluid (e.g., a glass of water). You may take Aprovel with or without food. Try to take the medicine at the same time each day. Treatment should be continued for as long as your doctor considers it necessary.

  • Patients with high blood pressure: The usual dose is 150 mg once daily (two tablets per day). The dose may be increased to 300 mg (four tablets per day) once daily, depending on the reduction in blood pressure levels.
  • Patients with high blood pressure and type 2 diabetes with kidney disease: In patients with high blood pressure and type 2 diabetes, the recommended maintenance dose is 300 mg (four tablets per day) once daily for the treatment of associated kidney disease.

Your doctor may decide to use lower doses, especially at the beginning of treatment, in particular patients such as those undergoing haemodialysis, or in patients over 75 years of age.
Maximum antihypertensive effect should be achieved within 4–6 weeks after starting treatment.

Use in children and adolescents
Aprovel must not be given to children under 18 years of age. If a child takes any tablets, contact your doctor immediately.

If you take more Aprovel than you should
If you accidentally take too many tablets, contact your doctor immediately.

If you forget to take Aprovel
If you accidentally miss a dose, continue with your next dose as usual. Do not take a double dose to make up for the forgotten dose.

If you have any doubts about how to use this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Some of these side effects may be serious and may require immediate medical attention.
As with similar medicines, rare cases of skin allergic reactions (redness, rash) as well as localized swelling of the face, lips and/or tongue have been reported in patients treated with irbesartan. If you experience any of these symptoms or have difficulty breathing, stop taking Aprovel and contact your doctor immediately.

The frequency of the side effects listed below is defined using the following convention:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people

The side effects reported in clinical studies in patients treated with Aprovel are:

  • Very common (may affect more than 1 in 10 people): if you have high blood pressure, type 2 diabetes and kidney disease, blood tests may show high levels of potassium.
  • Common (may affect up to 1 in 10 people): dizziness, feeling unwell/nausea, fatigue, and blood tests may show increased levels of an enzyme that measures muscle and heart function (creatine kinase). In patients with high blood pressure, type 2 diabetes and kidney disease, dizziness upon standing up from lying or sitting position, low blood pressure upon standing up from lying or sitting position, joint or muscle pain, and decreased levels of a protein in red blood cells (haemoglobin) have also been reported.
  • Uncommon (may affect up to 1 in 100 people): increased heart rate, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems related to sexual performance), chest pain.

Additional side effects have been reported since Aprovel has been marketed. The side effects with unknown frequency are: sensation of dizziness, headache, taste disturbances, ringing in the ears, muscle cramps, joint and muscle pain, reduced number of red blood cells (anaemia - symptoms may include tiredness, headache, shortness of breath during physical activity, dizziness and pale appearance), reduced platelet count, abnormal liver function, increased potassium levels in the blood, impaired kidney function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis), severe allergic reactions (anaphylactic shock). Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist.
You can also report side effects directly via the national reporting system detailed in Annex V.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Aprorel

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after Exp.
The expiry date refers to the last day of the month.
Do not store above 30°C.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to
dispose of medicines no longer required. This will help protect the environment.

6. Package contents and other information

What Aprovel contains

    • The active substance is irbesartan. Each Aprovel 75 mg tablet contains 75 mg of irbesartan.
    • The excipients are: microcrystalline cellulose, cross-linked sodium carboxymethylcellulose, lactose monohydrate, magnesium stearate, hydrated colloidal silica, pregelatinized corn starch and poloxamer 188. See section 2 “Aprovel contains lactose”.

Description of the appearance of Aprovel and contents of the pack
Aprovel 75 mg tablets are white to almost white, biconvex, oval-shaped, with a heart engraved on one side and the number 2771 imprinted on the other side.
Aprovel 75 mg tablets are available in packs of 14, 28, 56 or 98 tablets in blisters. Single-dose blisters of 56 x 1 tablet are also available for hospital use.
Not all pack sizes may be marketed.

Marketing Authorization Holder:
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France

Manufacturer:
SANOFI WINTHROP INDUSTRIE
1, rue de la Vierge
Ambarès & Lagrave
F-33565 Carbon Blanc Cedex - France
SANOFI WINTHROP INDUSTRIE
30-36 Avenue Gustave Eiffel, BP 7166
F-37071 Tours Cedex 2 - France

For further information about this medicinal product, please contact the local representative of the Marketing Authorization Holder:

België/Belgique/Belgien Lietuva
Sanofi Belgium Swixx Biopharma UAB Tel: +370 5 236 91 40
Tél/Tel: +32 (0)2 710 54 00

България Luxembourg/Luxemburg
Swixx Biopharma EOOD Sanofi Belgium
Тел.: +359 (0)2 4942 480 Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)

Česká republika Magyarország
sanofi-aventis, s.r.o. SANOFI-AVENTIS Zrt.
Tel: +420 233 086 111 Tel.: +36 1 505 0050

Danmark Malta
Sanofi A/S Tlf: +45 45 16 70 00 Sanofi S.r.l.
Tel: +39 02 39394275

Deutschland Nederland
Sanofi-Aventis Deutschland GmbH Genzyme Europe B.V.
Tel: 0800 52 52 010 Tel: +31 20 245 4000
Tel. aus dem Ausland: +49 69 305 21 131

Eesti Norge
Swixx Biopharma OÜ sanofi-aventis Norge AS
Tel: +372 640 10 30 Tlf: +47 67 10 71 00

Ελλάδα Österreich
Sanofi-Aventis Μονοπρόσωπη ΑΕΒΕ sanofi-aventis GmbH
Τηλ: +30 210 900 16 00 Tel: +43 1 80 185 – 0

España Polska
sanofi-aventis, S.A. sanofi-aventis Sp. z o.o.
Tel: +34 93 485 94 00 Tel.: +48 22 280 00 00

France Portugal
sanofi-aventis France Sanofi - Produtos Farmacêuticos, Lda
Tél: 0 800 222 555 Tel: +351 21 35 89 400
Appel depuis l’étranger : +33 1 57 63 23 23

Hrvatska România
Swixx Biopharma d.o.o. Sanofi Romania SRL
Tel: +385 1 2078 500 Tel: +40 (0) 21 317 31 36

Ireland Slovenija
sanofi-aventis Ireland Ltd. T/A SANOFI Swixx Biopharma d.o.o.
Tel: +353 (0) 1 403 56 00 Tel: +386 1 235 51 00

Ísland Slovenská republika
Vistor hf. Swixx Biopharma s.r.o.
Sími: +354 535 7000 Tel: +421 2 208 33 600

Italia Suomi/Finland
Sanofi S.r.l. Sanofi Oy
Tel: 800 536389 Puh/Tel: +358 (0) 201 200 300

Κύπρος Sverige
C.A. Papaellinas Ltd Sanofi AB
Τηλ: +357 22 741741 Tel: +46 (0)8 634 50 00

Latvija United Kingdom (Northern Ireland)
Swixx Biopharma SIA sanofi-aventis Ireland Ltd. T/A SANOFI
Tel: +371 6 616 47 50 Tel: +44 (0) 800 035 2525

More detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu/

Patient Information Leaflet

Aprovel 150 mg tablets

irbesartan
Please read this leaflet carefully before taking this medicine because it contains
important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not give it to others. It may be harmful to other people, even if their symptoms are the same as yours.
  • If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. See section 4.

Contents of this leaflet:

  1. What Aprovel is and what it is used for
  2. What you need to know before taking Aprovel
  3. How to take Aprovel
  4. Possible side effects
  5. How to store Aprovel
  6. Contents of the pack and other information

1. What Aprovel is and what it is used for

Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced by the body that binds to receptors in blood vessels, causing them to narrow. This results in increased blood pressure. Aprovel prevents angiotensin-II from binding to these receptors, allowing blood vessels to dilate and thereby reducing blood pressure. Aprovel slows the decline in renal function in patients with high blood pressure and type 2 diabetes.
Aprovel is used in adult patients

  • to treat high blood pressure ( essential hypertension )
  • to protect the kidneys in hypertensive patients with high blood pressure, type 2 diabetes, and evidence of kidney dysfunction shown by laboratory tests.

2. What you need to know before taking Aprovel

Do not take Aprovel:

    • if you are allergic to irbesartan or to any of the other ingredients of this medicine (listed in section 6)
    • if you are more than 3 months pregnant (it is better to avoid taking Aprovel even in the early stages of pregnancy – see Pregnancy section)
  • if you have diabetes or impaired kidney function and are being treated with a blood pressure-lowering medicine containing aliskiren

Warnings and precautions
Talk to your doctor before taking Aprovel if you are in any of the following conditions:

  • excessive vomiting or diarrhoea
  • if you have kidney problems
  • if you have heart problems
  • if you are taking Aprovel for diabetic kidney disorders. In this case, your doctor may prescribe regular blood tests, especially to monitor serum potassium levels in case of poor kidney function
  • if you develop low blood sugar levels (symptoms may include sweating, weakness, hunger, dizziness, trembling, headache, flushing or pallor, numbness, rapid and pounding heartbeat), especially if you are being treated for diabetes
  • if you are due to have surgery or take anaesthetics
  • if you are taking any of the following medicines used to treat high blood pressure:
  • an "ACE inhibitor" (e.g. enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes
  • aliskiren. Your doctor may monitor your kidney function, blood pressure, and blood electrolyte levels (e.g. potassium) at regular intervals.

See also the information under the section "Do not take Aprovel".
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming pregnant). Aprovel is not recommended during early pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to the unborn baby if taken during this period (see section Pregnancy).
Children and adolescents
This medicine must not be used in children and adolescents, as its safety and efficacy have not yet been fully established.
Other medicines and Aprovel
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor may consider it necessary to adjust your dose and/or take additional precautions:
If you are taking an ACE inhibitor or aliskiren (see also the sections "Do not take Aprovel" and "Warnings and precautions").
You may need blood tests if you are taking:

  • potassium supplements
  • salt substitutes containing potassium
  • potassium-sparing medicines (such as certain diuretics)
  • medicines containing lithium
  • repaglinide (a medicine used to lower blood sugar levels).

If you take certain painkillers called non-steroidal anti-inflammatory drugs (NSAIDs), the effectiveness of irbesartan may be reduced.
Aprovel with food and drink
Aprovel can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming pregnant). Your doctor will usually advise you to stop taking Aprovel before becoming pregnant or as soon as you know you are pregnant, and will recommend another medicine instead of Aprovel. Aprovel is not recommended during early pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to the unborn baby if taken after the third month of pregnancy.
Breast-feeding
Inform your doctor if you are breastfeeding or about to start breastfeeding. Aprovel is not recommended for women who are breastfeeding, and your doctor may choose another treatment if you wish to breastfeed, especially if the baby is a newborn or was born prematurely.
Driving and using machines
It is unlikely that Aprovel will affect your ability to drive or use machines. However, occasionally, dizziness or fatigue may occur during treatment for high blood pressure. If this happens, talk to your doctor before driving or operating machinery.
Aprovel contains lactose. If your doctor has diagnosed you with an intolerance to certain sugars, contact him/her before taking this medicine.
Aprovel contains sodium. This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e. it is essentially ‘sodium-free’.

3. How to take Aprovel

Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Method of administration
Aprovel is for oral use. Swallow the tablets with a sufficient amount of fluid (for example: a glass of water). You may take Aprovel with or without food. Try to take the medicine at the same time each day. Treatment should be continued for as long as your doctor considers it necessary.

  • Patients with high blood pressure: The usual dose is 150 mg once daily. The dose may be increased to 300 mg (two tablets) once daily, depending on the reduction in blood pressure levels.
  • Patients with high blood pressure and type 2 diabetes with kidney disease: In patients with high blood pressure and type 2 diabetes, the recommended maintenance dose is 300 mg (two tablets) once daily for the treatment of associated kidney disease.

Your doctor may decide to use lower doses, especially at the beginning of treatment, in particular patients such as those on haemodialysis, or in patients over 75 years of age.
Maximum antihypertensive effect should be achieved within 4–6 weeks after starting therapy.
Use in children and adolescents
Aprovel must not be given to children under 18 years of age. If a child takes any tablets, contact your doctor immediately.
If you take more Aprovel than you should
If you accidentally take too many tablets, contact your doctor immediately.
If you forget to take Aprovel
If you accidentally miss a dose, continue taking the medicine as normally scheduled. Do not take a double dose to make up for the forgotten dose.
If you have any doubts about how to use this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some of these side effects can be serious and may require medical attention.
As with similar medicines, rare cases of skin allergic reactions (redness, rash) as well as localized swelling of the face, lips and/or tongue have been reported in patients treated with irbesartan. If you experience any of these symptoms or have difficulty breathing, stop taking Aprovel and contact your doctor immediately.

The frequency of the side effects listed below is defined using the following convention:
Very common: may occur in more than 1 out of 10 people
Common: may occur in up to 1 out of 10 people
Uncommon: may occur in up to 1 out of 100 people

The side effects reported in clinical studies in patients treated with Aprovel are:

  • Very common (may occur in more than 1 out of 10 people): if you have high blood pressure, type 2 diabetes and kidney disease, blood tests may show high levels of potassium.
  • Common (may occur in up to 1 out of 10 people): dizziness, feeling unwell/nausea, fatigue, and blood tests may show increased levels of an enzyme that measures muscle and heart function (creatine kinase). In patients with high blood pressure, type 2 diabetes and kidney disease, dizziness upon standing up from lying or sitting position, low blood pressure upon standing up from lying or sitting position, joint or muscle pain, and decreased levels of a protein in red blood cells (haemoglobin) have also been reported.
  • Uncommon (may occur in up to 1 out of 100 people): increased heart rate, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems related to sexual performance), chest pain.

Additional side effects have been reported since Aprovel has been marketed. Side effects with unknown frequency include: sensation of dizziness, headache, taste disturbances, ringing in the ears, muscle cramps, joint and muscle pain, decreased number of red blood cells (anaemia - symptoms may include tiredness, headache, shortness of breath during physical activity, dizziness and pale appearance), reduced number of platelets, abnormal liver function, increased blood potassium levels, disturbances in kidney function, inflammation of the small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis), severe allergic reactions (anaphylactic shock). Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system listed in Annex V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Aprorel

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after Exp.
The expiry date refers to the last day of the month.
Do not store above 30°C.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Aprovel contains

    • The active substance is irbesartan. Each Aprovel 150 mg tablet contains 150 mg of irbesartan.
    • The other ingredients are: microcrystalline cellulose, cross-linked sodium carmellose, monohydrate lactose, magnesium stearate, hydrated colloidal silica, pregelatinized corn starch and poloxamer 188. See section 2 "Aprovel contains lactose".

Description of the appearance of Aprovel and the contents of the pack
Aprovel 150 mg tablets are white to almost white, biconvex, oval-shaped, with a heart-shaped imprint on one side and the number 2772 engraved on the other side.
Aprovel 150 mg tablets are available in packs of 14, 28, 56 or 98 tablets in blisters. Single-dose blisters of 56 x 1 tablet for hospital use are also available.
Not all pack sizes may be marketed.

Marketing Authorization Holder:
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France

Manufacturer:
SANOFI WINTHROP INDUSTRIE
1, rue de la Vierge
Ambarès & Lagrave
F-33565 Carbon Blanc Cedex - France
SANOFI WINTHROP INDUSTRIE
30-36 Avenue Gustave Eiffel, BP 7166
F-37071 Tours Cedex 2 - France

For further information about this medicinal product, please contact the local representative of the Marketing Authorization Holder:

België/Belgique/Belgien Lietuva
Sanofi Belgium Swixx Biopharma UAB
Tél/Tel: +32 (0)2 710 54 00 Tel: +370 5 236 91 40

България Luxembourg/Luxemburg
Swixx Biopharma EOOD Sanofi Belgium
Тел.: +359 (0)2 4942 480 Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)

Česká republika Magyarország
sanofi-aventis, s.r.o. SANOFI-AVENTIS Zrt.
Tel: +420 233 086 111 Tel.: +36 1 505 0050

Danmark Malta
Sanofi A/STlf: +45 45 16 70 00 Sanofi S.r.l.
Tel: +39 02 39394275

Deutschland Nederland
Sanofi-Aventis Deutschland GmbH Genzyme Europe B.V.
Tel: 0800 52 52 010 Tel: +31 20 245 4000
Tel. aus dem Ausland: +49 69 305 21 131

Eesti Norge
Swixx Biopharma OÜ sanofi-aventis Norge AS
Tel: +372 640 10 30 Tlf: +47 67 10 71 00

Ελλάδα Österreich
Sanofi-Aventis Μονοπρόσωπη ΑΕΒΕ sanofi-aventis GmbH
Τηλ: +30 210 900 16 00 Tel: +43 1 80 185 – 0

España Polska
sanofi-aventis, S.A. sanofi-aventis Sp. z o.o.
Tel: +34 93 485 94 00 Tel.: +48 22 280 00 00

France Portugal
sanofi-aventis France Sanofi - Produtos Farmacêuticos, Lda
Tél: 0 800 222 555 Tel: +351 21 35 89 400
Appel depuis l’étranger : +33 1 57 63 23 23

Hrvatska România
Swixx Biopharma d.o.o. Sanofi Romania SRL
Tel: +385 1 2078 500 Tel: +40 (0) 21 317 31 36

Ireland Slovenija
sanofi-aventis Ireland Ltd. T/A SANOFI Swixx Biopharma d.o.o.
Tel: +353 (0) 1 403 56 00 Tel: +386 1 235 51 00

Ísland Slovenská republika
Vistor hf. Swixx Biopharma s.r.o.
Sími: +354 535 7000 Tel: +421 2 208 33 600

Italia Suomi/Finland
Sanofi S.r.l. Sanofi Oy
Tel: 800 536389 Puh/Tel: +358 (0) 201 200 300

Κύπρος Sverige
C.A. Papaellinas Ltd Sanofi AB
Τηλ: +357 22 741741 Tel: +46 (0)8 634 50 00

Latvija United Kingdom (Northern Ireland)
Swixx Biopharma SIA sanofi-aventis Ireland Ltd. T/A SANOFI
Tel: +371 6616 47 50 Tel: +44 (0) 800 035 2525

More detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu/

Patient Information Leaflet: Information for the patient

Aprovel 300 mg tablets

irbesartan
Please read this leaflet carefully before taking this medicine because it contains
important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not give it to others. It may be harmful to other people, even if their symptoms are the same as yours.
  • If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. See section 4.

Contents of this leaflet:

  1. What Aprovel is and what it is used for
  2. What you need to know before taking Aprovel
  3. How to take Aprovel
  4. Possible side effects
  5. How to store Aprovel
  6. Contents of the pack and other information

1. What Aprovel is and what it is used for

Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced by the body that binds to receptors in blood vessels, causing them to constrict. This leads to an increase in blood pressure. Aprovel prevents angiotensin-II from binding to these receptors, allowing blood vessels to dilate and blood pressure to decrease. Aprovel slows the decline in kidney function in patients with high blood pressure and type 2 diabetes.
Aprovel is used in adult patients

  • to treat high blood pressure ( essential hypertension )
  • to protect the kidneys in hypertensive patients with high blood pressure, type 2 diabetes, and evidence of kidney dysfunction shown by laboratory tests.

2. What you need to know before taking Aprovel

Do not take Aprovel:

    • if you are allergic to irbesartan or to any of the other ingredients of this medicine (listed in section 6)
    • if you are more than 3 months pregnant (it is best to avoid taking Aprovel even in the early stages of pregnancy – see Pregnancy section)
  • if you have diabetes or impaired kidney function and are being treated with a blood pressure-lowering medicine containing aliskiren

Warnings and precautions
Talk to your doctor before taking Aprovel if you are in any of the following conditions:

  • excessive vomiting or diarrhoea
  • if you suffer from kidney problems
  • if you suffer from heart problems
  • if you are taking Aprovel for diabetic kidney disorders. In this case, your doctor may prescribe regular blood tests, especially to monitor serum potassium levels in case of poor kidney function
  • if you develop low blood sugar levels (symptoms may include sweating, weakness, hunger, dizziness, tremor, headache, flushing or pallor, numbness, rapid and pounding heartbeat), particularly if you are being treated for diabetes
  • if you are scheduled for surgery or taking anaesthetics
  • if you are taking any of the following medicines used to treat high blood pressure:
  • an "ACE inhibitor” (e.g. enalapril, lisinopril, ramipril), especially if you have kidney problems related to diabetes
  • aliskiren. Your doctor may regularly monitor your kidney function, blood pressure, and blood electrolyte levels (e.g. potassium).

See also information under the section "Do not take Aprovel".
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming
pregnant). Aprovel is not recommended during early pregnancy and must not be taken after the first
3 months of pregnancy, as it may cause serious harm to the unborn baby if taken during this period (see
section Pregnancy).
Children and adolescents
This medicine should not be used in children and adolescents, as its safety and efficacy have not yet
been fully established.
Other medicines and Aprovel
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor may consider it necessary to adjust your dose and/or take additional precautions:
If you are taking an ACE inhibitor or aliskiren (see also the sections "Do not take Aprovel" and "Warnings and precautions").
You may need blood tests if you are taking:

  • potassium supplements
  • potassium-containing salt substitutes
  • potassium-sparing medicines (such as certain diuretics)
  • medicines containing lithium
  • repaglinide (a medicine used to lower blood sugar levels).

If you are taking certain painkillers called non-steroidal anti-inflammatory drugs (NSAIDs), the
effectiveness of irbesartan may be reduced.
Aprovel with food and drink
Aprovel can be taken with or without food.
Pregnancy and breast-feeding
Pregnancy
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming
pregnant). Your doctor will usually advise you to stop taking Aprovel before becoming pregnant or as
soon as pregnancy is confirmed, and will recommend an alternative medicine. Aprovel is not
recommended during early pregnancy and must not be taken after the first 3 months of pregnancy, as it
may cause serious harm to the unborn baby if taken beyond the third month of pregnancy.
Breast-feeding
Inform your doctor if you are breast-feeding or planning to breast-feed. Aprovel is not recommended for
women who are breast-feeding, and your doctor may choose an alternative treatment if you wish to
breast-feed, especially if the baby is a newborn or was born prematurely.
Driving and using machines
It is unlikely that Aprovel will affect your ability to drive or operate machinery. However, occasionally,
dizziness or fatigue may occur during treatment for high blood pressure. If this happens, talk to your
doctor before driving or operating machinery.
Aprovel contains lactose. If your doctor has diagnosed you with an intolerance to certain sugars,
contact him/her before taking this medicine.
Aprovel contains sodium. This medicine contains less than 1 mmol of sodium (23 mg) per
tablet, i.e. it is essentially ‘sodium-free’.

3. How to take Aprovel

Take this medicine exactly as your doctor has told you. If you are unsure, consult your doctor or pharmacist.
Method of administration
Aprovel is for oral use. Swallow the tablets with a sufficient amount of fluid (for example: a glass of water). You may take Aprovel with or without food. Try to take the medicine at the same time each day. Treatment should be continued for as long as your doctor considers it necessary.

  • Patients with high blood pressure: The usual dose is 150 mg once daily. The dose may be increased to 300 mg once daily, depending on the reduction in blood pressure levels.
  • Patients with high blood pressure and type 2 diabetes with kidney disease: In patients with high blood pressure and type 2 diabetes, the recommended maintenance dose is 300 mg once daily for the treatment of associated kidney disease.

Your doctor may decide to use lower doses, especially at the beginning of treatment, in particular patients such as those on haemodialysis, or in patients over 75 years of age.
Maximum antihypertensive effect should be achieved within 4 to 6 weeks after starting therapy.
Use in children and adolescents
Aprovel must not be given to children under 18 years of age. If a child ingests any tablets, contact your doctor immediately.
If you take more Aprovel than you should
If you accidentally take too many tablets, contact your doctor immediately.
If you forget to take Aprovel
If you accidentally miss a dose, continue with your next dose as usual. Do not take a double dose to make up for the missed dose.
If you have any doubts about how to use this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some of these side effects may be serious and may require medical attention.
As with similar medicines, rare cases of skin allergic reactions (rash, urticaria) as well as localized swelling of the face, lips and/or tongue have been reported in patients treated with irbesartan. If you experience any of these symptoms or have difficulty breathing, stop taking Aprovel and contact your doctor immediately.

The frequency of the side effects listed below is defined using the following convention:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people

The side effects reported in clinical studies in patients treated with Aprovel are:

  • Very common (may affect more than 1 in 10 people): If you have high blood pressure and type 2 diabetes with kidney disease, blood tests may show high levels of potassium.
  • Common (may affect up to 1 in 10 people): dizziness, feeling unwell/nausea, fatigue, and blood tests may show increased levels of an enzyme that measures muscle and heart function (creatine kinase). In patients with high blood pressure and type 2 diabetes with kidney disease, dizziness upon standing from a lying or sitting position, low blood pressure upon standing from a lying or sitting position, joint or muscle pain, and decreased levels of a protein in red blood cells (haemoglobin) have also been reported.
  • Uncommon (may affect up to 1 in 100 people): increased heart rate, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems related to sexual performance), chest pain.

Additional side effects have been reported since Aprovel has been marketed. The side effects with unknown frequency include: sensation of dizziness, headache, taste disturbances, ringing in the ears, muscle cramps, joint and muscle pain, decreased number of red blood cells (anaemia - symptoms may include tiredness, headache, shortness of breath during physical activity, dizziness and pale appearance), reduced number of platelets, abnormal liver function, increased potassium levels in the blood, impaired kidney function, inflammation of the small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis), and severe allergic reactions (anaphylactic shock). Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist.
You can also report side effects directly via the national reporting system detailed in Annex V.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Aprovel

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after Exp.
The expiry date refers to the last day of the month.
Do not store above 30°C.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Aprovel contains

    • The active substance is irbesartan. Each Aprovel 300 mg tablet contains 300 mg of irbesartan.
    • The excipients are: microcrystalline cellulose, cross-linked sodium carmellose, monohydrate lactose, magnesium stearate, hydrated colloidal silica, pregelatinized corn starch and poloxamer 188. See section 2 “Aprovel contains lactose”.

Description of the appearance of Aprovel and the contents of the pack
Aprovel 300 mg tablets are white to almost white, biconvex, oval-shaped, with a heart-shaped imprint on one side and the number 2773 engraved on the other side.
Aprovel 300 mg tablets are available in packs of 14, 28, 56 or 98 tablets in blisters. Single-dose blisters containing 56 x 1 tablet for hospital use are also available.
Not all pack sizes may be marketed.

Marketing Authorization Holder:
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France

Manufacturer:
SANOFI WINTHROP INDUSTRIE
1, rue de la Vierge
Ambarès & Lagrave
F-33565 Carbon Blanc Cedex - France
SANOFI WINTHROP INDUSTRIE
30-36 Avenue Gustave Eiffel, BP 7166
F-37071 Tours Cedex 2 - France

For further information about this medicinal product, please contact the local representative of the Marketing Authorization Holder:

België/Belgique/Belgien Lietuva
Sanofi Belgium Swixx Biopharma UAB
Tél/Tel: +32 (0)2 710 54 00 Tel: +370 5 236 91 40

България Luxembourg/Luxemburg
Swixx Biopharma EOOD Sanofi Belgium
Тел.: +359 (0)2 4942 480 Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)

Česká republika Magyarország
sanofi-aventis, s.r.o. SANOFI-AVENTIS Zrt.
Tel: +420 233 086 111 Tel.: +36 1 505 0050

Danmark Malta
Sanofi A/S Tlf: +45 45 16 70 00 Sanofi S.r.l.
Tel: +39 02 39394275

Deutschland Nederland
Sanofi-Aventis Deutschland GmbH Genzyme Europe B.V.
Tel: 0800 52 52 010 Tel: +31 20 245 4000
Tel. from abroad: +49 69 305 21 131

Eesti Norge
Swixx Biopharma OÜ sanofi-aventis Norge AS
Tel: +372 640 10 30 Tlf: +47 67 10 71 00

Ελλάδα Österreich
Sanofi-Aventis Μονοπρόσωπη ΑΕΒΕ sanofi-aventis GmbH
Τηλ: +30 210 900 16 00 Tel: +43 1 80 185 – 0

España Polska
sanofi-aventis, S.A. sanofi-aventis Sp. z o.o.
Tel: +34 93 485 94 00 Tel.: +48 22 280 00 00

France Portugal
sanofi-aventis France Sanofi - Produtos Farmacêuticos, Lda
Tél: 0 800 222 555 Tel: +351 21 35 89 400
From abroad: +33 1 57 63 23 23

Hrvatska România
Swixx Biopharma d.o.o. Sanofi Romania SRL
Tel: +385 1 2078 500 Tel: +40 (0) 21 317 31 36

Ireland Slovenija
sanofi-aventis Ireland Ltd. T/A SANOFI Swixx Biopharma d.o.o.
Tel: +353 (0) 1 403 56 00 Tel: +386 1 235 51 00

Ísland Slovenská republika
Vistor hf. Swixx Biopharma s.r.o.
Sími: +354 535 7000 Tel: +421 2 208 33 600

Italia Suomi/Finland
Sanofi S.r.l. Sanofi Oy
Tel: 800 536389 Puh/Tel: +358 (0) 201 200 300

Κύπρος Sverige
C.A. Papaellinas Ltd Sanofi AB
Τηλ: +357 22 741741 Tel: +46 (0)8 634 50 00

Latvija United Kingdom (Northern Ireland)
Swixx Biopharma SIA sanofi-aventis Ireland Ltd. T/A SANOFI
Tel: +371 6616 47 50 Tel: +44 (0) 800 035 2525

More detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu/

Patient Information Leaflet

Aprovel 75 mg film-coated tablets

irbesartan
Please read this leaflet carefully before taking this medicine because it contains
important information for you.

    • Keep this leaflet. You may need to read it again.
    • If you have any questions, ask your doctor or pharmacist.
    • This medicine has been prescribed for you only. Do not give it to others. This medicine may be harmful to others, even if their symptoms are the same as yours.
  • If you experience any adverse reaction, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.

Contents of this leaflet:

  1. What Aprovel is and what it is used for
  2. What you need to know before taking Aprovel
  3. How to take Aprovel
  4. Possible side effects
  5. How to store Aprovel
  6. Contents of the pack and other information

1. What Aprovel is and what it is used for

Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced by the body that binds to receptors in blood vessels, causing them to constrict. This leads to an increase in blood pressure. Aprovel prevents angiotensin-II from binding to these receptors, allowing blood vessels to dilate and blood pressure to decrease. Aprovel slows the decline in kidney function in patients with high blood pressure and type 2 diabetes.
Aprovel is used in adult patients

  • to treat high levels of blood pressure ( essential hypertension )
  • to protect the kidneys in hypertensive patients with high blood pressure, type 2 diabetes, and evidence of kidney dysfunction shown by laboratory tests.

2. What you need to know before taking Aprovel

Do not take Aprovel:

  • if you are allergic to irbesartan or to any of the other ingredients of this medicine (listed in section 6)
  • if you are more than 3 months pregnant (it is best to avoid taking Aprovel even in early pregnancy - see Pregnancy section)
  • if you have diabetes or impaired kidney function and are being treated with a blood pressure-lowering medicine containing aliskiren

Warnings and precautions
Talk to your doctor before taking Aprovel if you are in any of the following conditions:

    • excessive vomiting or diarrhoea
    • if you suffer from kidney disorders
    • if you suffer from heart disorders
  • if you are taking Aprovel for diabetic kidney disease. In this case, your doctor may prescribe regular blood tests, especially to monitor serum potassium levels in case of poor kidney function
  • if you develop low blood sugar levels (symptoms may include sweating, weakness, hunger, dizziness, tremor, headache, flushing or paleness, numbness, rapid and pounding heartbeat), especially if you are being treated for diabetes
    • if you are scheduled for surgery or require anaesthetics
  • if you are taking any of the following medicines used to treat high blood pressure:
  • an "ACE inhibitor" (e.g. enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes.
  • aliskiren

Your doctor may monitor your kidney function, blood pressure, and levels of electrolytes
(e.g. potassium) in your blood at regular intervals.
See also the information under the heading "Do not take Aprovel".
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming
pregnant). Aprovel is not recommended during early pregnancy and must not be taken after the first
3 months of pregnancy, as it may cause serious harm to the unborn child if taken during this period (see section Pregnancy).
Children and adolescents
This medicine should not be used in children and adolescents, as its safety and efficacy have not yet been fully established.
Other medicines and Aprovel
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor may consider it necessary to adjust your dose and/or take additional precautions:
If you are taking an ACE inhibitor or aliskiren (see also the sections "Do not take Aprovel" and "Warnings and precautions").
You may need blood tests if you are taking:

  • potassium supplements
  • potassium-containing salt substitutes
  • potassium-sparing medicines (such as certain diuretics)
  • lithium-containing medicines
  • repaglinide (a medicine used to lower blood sugar levels).

If you are taking certain painkillers, known as non-steroidal anti-inflammatory drugs (NSAIDs),
the effectiveness of irbesartan may be reduced.
Aprovel with food and drink
Aprovel can be taken with or without food.
Pregnancy and breast-feeding
Pregnancy
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming pregnant); your doctor will usually advise you to stop taking Aprovel before becoming pregnant or as soon as pregnancy is confirmed, and will recommend an alternative medicine instead of Aprovel. Aprovel is not recommended during early pregnancy and must not be taken after the first 3 months of pregnancy, as it may cause serious harm to the unborn child if taken beyond the third month of pregnancy.
Breast-feeding
Inform your doctor if you are breast-feeding or about to start breast-feeding. Aprovel is not recommended for women who are breast-feeding, and your doctor may choose an alternative treatment if you wish to breast-feed, especially if the baby is a newborn or was born prematurely.
Driving and using machines:
It is unlikely that Aprovel will affect your ability to drive or use machines. However, occasionally, dizziness or fatigue may occur during treatment for high blood pressure. If this happens, talk to your doctor before driving or operating machinery.
Aprovel contains lactose. If your doctor has diagnosed you with an intolerance to certain sugars, contact him/her before taking this medicine.
Aprovel contains sodium. This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e. it is essentially 'sodium-free'.

3. How to take Aprovel

Take this medicine exactly as your doctor has told you. If you are unsure, consult your doctor or pharmacist.
Method of administration
Aprovel is for oral use. Swallow the tablets with a sufficient amount of fluid (for example: a glass of water). You may take Aprovel with or without food. Try to take the medicine at the same time each day. Treatment should be continued as long as your doctor considers it necessary.

  • Patients with high blood pressure: The usual dose is 150 mg once daily (two tablets per day). The dose may subsequently be increased to 300 mg (four tablets per day) once daily, depending on the reduction in blood pressure levels.
  • Patients with high blood pressure and type 2 diabetes with kidney disease: In patients with high blood pressure and type 2 diabetes, the recommended maintenance dose is 300 mg (four tablets per day) once daily for the treatment of associated kidney disease.

Your doctor may decide to use lower doses, especially at the beginning of treatment, in particular patients such as those on haemodialysis, or in patients over 75 years of age.
Maximum antihypertensive effect should be achieved within 4–6 weeks after starting therapy.
Use in children and adolescents
Aprovel must not be given to children under 18 years of age. If a child swallows any tablets, contact a doctor immediately.
If you take more Aprovel than you should
If you accidentally take too many tablets, contact your doctor immediately.
If you forget to take Aprovel
If you accidentally miss a dose, continue with your regular dosing schedule. Do not take a double dose to make up for the missed dose.
If you have any doubts about how to use this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.
Some of these effects can be serious and may require medical attention.
As with similar medicines, rare cases of skin allergic reactions (rash, urticaria) as well as localized swelling of the face, lips and/or tongue have been reported in patients treated with irbesartan. If you experience any of these symptoms or have difficulty breathing, stop taking Aprovel and contact your doctor immediately.
The frequency of the side effects listed below is defined using the following convention:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people

The side effects reported in clinical studies in patients treated with Aprovel were:

  • Very common (may affect more than 1 in 10 people): if you have high blood pressure, type 2 diabetes and kidney disease, blood tests may show elevated potassium levels.
  • Common (may affect up to 1 in 10 people): dizziness, feeling unwell/nausea, fatigue, and blood tests may show increased levels of an enzyme that measures muscle and heart function (creatine kinase). In patients with high blood pressure, type 2 diabetes and kidney disease, dizziness upon standing from lying or sitting position, low blood pressure upon standing from lying or sitting position, joint or muscle pain, and decreased levels of a protein in red blood cells (haemoglobin) have also been reported.
  • Uncommon (may affect up to 1 in 100 people): increased heart rate, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems related to sexual performance), chest pain.

Additional side effects have been reported since Aprovel has been marketed. Side effects with unknown frequency include: sensation of dizziness, headache, taste disturbances, ringing in the ears, muscle cramps, joint and muscle pain, decreased number of red blood cells (anaemia - symptoms may include tiredness, headache, shortness of breath during physical activity, dizziness and pale appearance), reduced platelet count, abnormal liver function, increased blood potassium levels, impaired kidney function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis), severe allergic reactions (anaphylactic shock). Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist.
You can also report side effects directly via the national reporting system listed in Annex V.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Aprovel

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the blister after Exp.
The expiry date refers to the last day of the month.
Do not store above 30°C.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Aprovel contains

    • The active substance is irbesartan. Each Aprovel 75 mg tablet contains 75 mg of irbesartan.
    • The excipients are: monohydrate lactose, microcrystalline cellulose, cross-linked sodium carmellose, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3000, carnauba wax. See section 2 “Aprovel contains lactose”.

Description of the appearance of Aprovel and contents of the pack
Aprovel 75 mg film-coated tablets are white to almost white, biconvex, oval-shaped tablets with a heart engraved on one side and the number 2871 imprinted on the other side.
Aprovel 75 mg film-coated tablets are available in packs of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters. Single-dose blisters are also available, containing 56 x 1 film-coated tablet for hospital use.
Not all pack sizes may be marketed.
Marketing Authorization Holder:
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France
Manufacturer:
SANOFI WINTHROP INDUSTRIE
1, rue de la Vierge
Ambarès & Lagrave
F-33565 Carbon Blanc Cedex - France
SANOFI WINTHROP INDUSTRIE
30-36 Avenue Gustave Eiffel, BP 7166
F-37071 Tours Cedex 2 - France
For further information on this medicinal product, please contact the local representative of the Marketing Authorization Holder:
België/Belgique/Belgien Lietuva
Sanofi Belgium Swixx Biopharma UAB
Tél/Tel: +32 (0)2 710 54 00 Tel: +370 5 236 91 40
България Luxembourg/Luxemburg
Swixx Biopharma EOOD Sanofi Belgium
Тел.: +359 (0)2 4942 480 Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)
Česká republika Magyarország
sanofi-aventis, s.r.o. SANOFI-AVENTIS Zrt.
Tel: +420 233 086 111 Tel.: +36 1 505 0050
Danmark Malta
Sanofi A/STlf: +45 45 16 70 00 Sanofi S.r.l.
Tel: +39 02 39394275
Deutschland Nederland
Sanofi-Aventis Deutschland GmbH Genzyme Europe B.V.
Tel: 0800 52 52 010 Tel: +31 20 245 4000
Tel. from abroad: +49 69 305 21 131
Eesti Norge
Swixx Biopharma OÜ sanofi-aventis Norge AS
Tel: +372 640 10 30 Tlf: +47 67 10 71 00
Ελλάδα Österreich
Sanofi-Aventis Μονοπρόσωπη ΑΕΒΕ sanofi-aventis GmbH
Τηλ: +30 210 900 16 00 Tel: +43 1 80 185 – 0
España Polska
sanofi-aventis, S.A. sanofi-aventis Sp. z o.o.
Tel: +34 93 485 94 00 Tel.: +48 22 280 00 00
France Portugal
sanofi-aventis France Sanofi - Produtos Farmacêuticos, Lda
Tél: 0 800 222 555 Tel: +351 21 35 89 400
From abroad: +33 1 57 63 23 23
Hrvatska România
Swixx Biopharma d.o.o. Sanofi Romania SRL
Tel: +385 1 2078 500 Tel: +40 (0) 21 317 31 36
Ireland Slovenija
sanofi-aventis Ireland Ltd. T/A SANOFI Swixx Biopharma d.o.o.
Tel: +353 (0) 1 403 56 00 Tel: +386 1 235 51 00
Ísland Slovenská republika
Vistor hf. Swixx Biopharma s.r.o.
Sími: +354 535 7000 Tel: +421 2 208 33 600
Italia Suomi/Finland
Sanofi S.r.l. Sanofi Oy
Tel: 800 536389 Puh/Tel: +358 (0) 201 200 300
Κύπρος Sverige
C.A. Papaellinas Ltd Sanofi AB
Τηλ: +357 22 741741 Tel: +46 (0)8 634 50 00
Latvija United Kingdom (Northern Ireland)
Swixx Biopharma SIA sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44
Tel: +371 6616 47 50 (0) 800 035 2525
More detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu/

Patient Information Leaflet

Aprovel 150 mg film-coated tablets

irbesartan
Please read this leaflet carefully before taking this medicine because it contains
important information for you.

    • Keep this leaflet. You may need to read it again.
    • If you have any questions, ask your doctor or pharmacist.
    • This medicine has been prescribed for you only. Do not give it to others. It may be harmful to other people, even if their symptoms are the same as yours.
  • If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. See section 4.

Contents of this leaflet:

  1. What Aprovel is and what it is used for
  2. What you need to know before taking Aprovel
  3. How to take Aprovel
  4. Possible side effects
  5. How to store Aprovel
  6. Contents of the pack and other information

1. What Aprovel is and what it is used for

Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced by the body that binds to receptors in blood vessels, causing them to constrict. This leads to an increase in blood pressure. Aprovel prevents angiotensin-II from binding to these receptors, allowing blood vessels to dilate and blood pressure to decrease. Aprovel slows the decline in kidney function in patients with high blood pressure and type 2 diabetes.
Aprovel is used in adult patients

  • to treat high blood pressure ( essential arterial hypertension )
  • to protect the kidneys in hypertensive patients with high blood pressure, type 2 diabetes, and evidence of kidney dysfunction shown by laboratory tests.

2. What you should know before taking Aprovel

Do not take Aprovel:

  • if you are allergic to irbesartan or to any of the other ingredients of this medicine (listed in section 6)
  • if you are more than 3 months pregnant (it is better to avoid taking Aprovel even in the early stages of pregnancy – see Pregnancy section)
  • if you have diabetes or impaired kidney function and are being treated with a blood pressure-lowering medicine containing aliskiren

Warnings and precautions
Talk to your doctor before taking Aprovel if you are in any of the following conditions:

    • excessive vomiting or diarrhoea
    • if you suffer from kidney disorders
    • if you suffer from heart disorders
  • if you are taking Aprovel for diabetic kidney disease. In this case, your doctor may prescribe regular blood tests, especially to monitor serum potassium levels in case of poor kidney function
  • if you develop low blood sugar levels (symptoms may include sweating, weakness, hunger, dizziness, tremor, headache, flushing or paleness, numbness, rapid and pounding heartbeat), particularly if you are being treated for diabetes
    • if you are scheduled for surgery or taking anaesthetics
  • if you are taking any of the following medicines used to treat high blood pressure:
  • an "ACE inhibitor” (e.g. enalapril, lisinopril, ramipril), especially if you have kidney problems related to diabetes
  • aliskiren

Your doctor may check your kidney function, blood pressure, and blood electrolyte levels
(e.g. potassium) at regular intervals.
See also information under the section "Do not take Aprovel".
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming
pregnant). Aprovel is not recommended during early pregnancy and must not be taken if you are
more than 3 months pregnant, as it may cause severe harm to the unborn baby if taken during this
period (see Pregnancy section).
Children and adolescents
This medicine must not be used in children and adolescents, as its safety and efficacy have not yet been fully established.
Other medicines and Aprovel
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor may consider it necessary to adjust your dose and/or take additional precautions:
If you are taking an ACE inhibitor or aliskiren (see also information under "Do not take Aprovel" and "Warnings and precautions").
You may need blood tests if you are taking:

  • potassium supplements
  • potassium-containing salt substitutes
  • potassium-sparing medicines (such as certain diuretics)
  • medicines containing lithium
  • repaglinide (a medicine used to lower blood sugar levels)

When taking certain painkillers called non-steroidal anti-inflammatory drugs (NSAIDs), the effectiveness of irbesartan may be reduced.
Aprovel with food and drink
Aprovel can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming pregnant). Your doctor will usually advise you to stop taking Aprovel before becoming pregnant or as soon as pregnancy is confirmed, and will recommend an alternative medicine instead of Aprovel. Aprovel is not recommended during early pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to the unborn baby if taken after the third month of pregnancy.
Breastfeeding
Inform your doctor if you are breastfeeding or planning to breastfeed. Aprovel is not recommended for women who are breastfeeding, and your doctor may choose another treatment if you wish to breastfeed, especially if the baby is a newborn or was born prematurely.
Driving and using machines:
It is unlikely that Aprovel will affect your ability to drive or operate machinery. However, occasionally, dizziness or fatigue may occur during treatment for high blood pressure. If this happens, talk to your doctor before driving or using machinery.
Aprovel contains lactose. If your doctor has diagnosed you with an intolerance to certain sugars, contact him before taking this medicine.
Aprovel contains sodium. This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e. it is essentially ‘sodium-free’.

3. How to take Aprovel

Take this medicine exactly as your doctor has told you. If you are unsure, consult your doctor or pharmacist.
Method of administration
Aprovel is for oral use. Swallow the tablets with a sufficient amount of fluid (for example: a glass of water). You may take Aprovel with or without food. Try to take the medicine at the same time each day. Treatment should be continued for as long as your doctor considers it necessary.

  • Patients with high blood pressure: The usual dose is 150 mg once daily. The dosage may subsequently be increased to 300 mg (two tablets once daily) depending on the reduction in blood pressure levels.
  • Patients with high blood pressure and type 2 diabetes with kidney disease: In patients with high blood pressure and type 2 diabetes, the recommended maintenance dose is 300 mg (two tablets once daily) for the treatment of associated kidney disease.

Your doctor may decide to use lower doses, especially at the beginning of treatment, in particular patients such as those on haemodialysis, or in patients over 75 years of age.
Maximum antihypertensive effect should be achieved within 4–6 weeks after starting therapy.
Use in children and adolescents
Aprovel must not be given to children under 18 years of age. If a child swallows any tablets, contact your doctor immediately.
If you take more Aprovel than you should
If you accidentally take too many tablets, contact your doctor immediately.
If you forget to take Aprovel
If you accidentally miss a dose, continue with your next dose as normal. Do not take a double dose to make up for the missed dose.
If you have any doubts about how to use this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone experiences them.
Some of these side effects can be serious and may require medical attention.
As with similar medicines, rare cases of skin allergic reactions (rash, urticaria) as well as localized swelling of the face, lips and/or tongue have been reported in patients treated with irbesartan. If you experience any of these symptoms or have difficulty breathing, stop taking Aprovel and contact your doctor immediately.
The frequency of the side effects listed below is defined using the following convention:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people

The side effects reported in clinical studies for patients treated with Aprovel include:

  • Very common (may affect more than 1 in 10 people): if you have high blood pressure and type 2 diabetes with kidney disease, blood tests may show high levels of potassium.
  • Common (may affect up to 1 in 10 people): dizziness, feeling unwell/nausea, fatigue, and blood tests may show increased levels of an enzyme that measures muscle and heart function (creatine kinase). In patients with high blood pressure, type 2 diabetes and kidney disease, dizziness upon standing from lying or sitting position, low blood pressure upon standing from lying or sitting position, joint or muscle pain, and decreased levels of a protein in red blood cells (haemoglobin) have also been reported.
  • Uncommon (may affect up to 1 in 100 people): increased heart rate, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems related to sexual performance), chest pain.

Additional side effects have been reported since Aprovel has been marketed. The side effects with unknown frequency include: sensation of dizziness, headache, taste disturbances, ringing in the ears, muscle cramps, joint and muscle pain, reduced platelet count, abnormal liver function, increased blood potassium levels, decreased number of red blood cells (anaemia - symptoms may include tiredness, headache, shortness of breath during physical activity, dizziness and pale appearance), renal function disorders, inflammation of small blood vessels mainly affecting the skin (a condition known as leucocytoclastic vasculitis), severe allergic reactions (anaphylactic shock). Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, please consult your doctor or pharmacist.
You can also report side effects directly via the national reporting system listed in Annex V.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Aprovel

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after Exp.
The expiry date refers to the last day of the month.
Do not store above 30°C.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Aprovel contains

    • The active substance is irbesartan. Each Aprovel 150 mg tablet contains 150 mg of irbesartan.
    • The other ingredients (excipients) are: monohydrate lactose, microcrystalline cellulose, cross-linked sodium carmellose, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3000, carnauba wax. See section 2 “Aprovel contains lactose”. . Description of the appearance of Aprovel and the contents of the pack Aprovel 150 mg film-coated tablets are white to almost white, biconvex, oval-shaped tablets with a heart engraved on one side and the number 2872 imprinted on the other side.

Aprovel 150 mg film-coated tablets are available in packs of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters. Single-dose blisters are also available containing 56 x 1 film-coated tablet for hospital use.

Not all pack sizes may be marketed.

Marketing Authorization Holder:
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France

Manufacturer:
SANOFI WINTHROP INDUSTRIE
1, rue de la Vierge
Ambarès & Lagrave
F-33565 Carbon Blanc Cedex - France
SANOFI WINTHROP INDUSTRIE
30-36 Avenue Gustave Eiffel, BP 7166
F-37071 Tours Cedex 2 - France
Sanofi-Aventis, S.A.
Ctra. C-35 (La Batlloria-Hostalric), km. 63.09
17404 Riells i Viabrea (Girona)
Spain

For further information about this medicinal product, please contact the local representative of the Marketing Authorization Holder:

België/Belgique/Belgien Lietuva
Sanofi Belgium Swixx Biopharma UAB
Tél/Tel: +32 (0)2 710 54 00 Tel: +370 5 236 91 40

България Luxembourg/Luxemburg
Swixx Biopharma EOOD Sanofi Belgium
Тел.: +359 (0)2 4942 480 Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)

Česká republika Magyarország
sanofi-aventis, s.r.o. SANOFI-AVENTIS Zrt.
Tel: +420 233 086 111 Tel.: +36 1 505 0050

Danmark Malta
Sanofi A/STlf: +45 45 16 70 00 Sanofi S.r.l.
Tel: +39 02 39394275

Deutschland Nederland
Sanofi-Aventis Deutschland GmbH Genzyme Europe B.V.
Tel: 0800 52 52 010 Tel: +31 20 245 4000
Tel. aus dem Ausland: +49 69 305 21 131

Eesti Norge
Swixx Biopharma OÜ sanofi-aventis Norge AS
Tel: +372 640 10 30 Tlf: +47 67 10 71 00

Ελλάδα Österreich
Sanofi-Aventis Μονοπρόσωπη ΑΕΒΕ sanofi-aventis GmbH
Τηλ: +30 210 900 16 00 Tel: +43 1 80 185 – 0

España Polska
sanofi-aventis, S.A. sanofi-aventis Sp. z o.o.
Tel: +34 93 485 94 00 Tel.: +48 22 280 00 00

France Portugal
sanofi-aventis France Sanofi - Produtos Farmacêuticos, Lda
Tél: 0 800 222 555 Tel: +351 21 35 89 400
Appel depuis l’étranger : +33 1 57 63 23 23

Hrvatska România
Swixx Biopharma d.o.o. Sanofi Romania SRL
Tel: +385 1 2078 500 Tel: +40 (0) 21 317 31 36

Ireland Slovenija
sanofi-aventis Ireland Ltd. T/A SANOFI Swixx Biopharma d.o.o.
Tel: +353 (0) 1 403 56 00 Tel: +386 1 235 51 00

Ísland Slovenská republika
Vistor hf. Swixx Biopharma s.r.o.
Sími: +354 535 7000 Tel: +421 2 208 33 600

Italia Suomi/Finland
Sanofi S.r.l. Sanofi Oy
Tel: 800 536389 Puh/Tel: +358 (0) 201 200 300

Κύπρος Sverige
C.A. Papaellinas Ltd Sanofi AB
Τηλ: +357 22 741741 Tel: +46 (0)8 634 50 00

Latvija United Kingdom (Northern Ireland)
Swixx Biopharma SIA sanofi-aventis Ireland Ltd. T/A SANOFI
Tel: +371 6616 47 50 Tel: +44 (0) 800 035 2525

More detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu/

Patient Information Leaflet

Aprovel 300 mg film-coated tablets

irbesartan
Please read this leaflet carefully before taking this medicine because it contains
important information for you.

    • Keep this leaflet. You may need to read it again.
    • If you have any questions, ask your doctor or pharmacist.
    • This medicine has been prescribed for you only. Do not give it to others. It could be harmful to them, even if their symptoms are the same as yours.
  • If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. See section 4.

Contents of this leaflet:

  1. What Aprovel is and what it is used for
  2. What you need to know before taking Aprovel
  3. How to take Aprovel
  4. Possible side effects
  5. How to store Aprovel
  6. Contents of the pack and other information

1. What Aprovel is and what it is used for

Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced by the body that binds to receptors in blood vessels, causing them to constrict. This results in an increase in blood pressure. Aprovel prevents angiotensin-II from binding to these receptors, allowing blood vessels to dilate and blood pressure to decrease. Aprovel slows the decline in kidney function in patients with high blood pressure and type 2 diabetes.
Aprovel is used in adult patients

  • to treat high blood pressure ( essential hypertension )
  • to protect the kidneys in hypertensive patients with high blood pressure, type 2 diabetes, and evidence of kidney dysfunction shown by laboratory tests.

2. What you need to know before taking Aprovel

Do not take Aprovel:

  • if you are allergic to irbesartan or to any of the other ingredients of this medicine (listed in section 6)
  • if you are more than 3 months pregnant (it is better to avoid taking Aprovel even in the early stages of pregnancy – see Pregnancy section)
  • if you have diabetes or impaired kidney function and are being treated with a blood pressure-lowering medicine containing aliskiren

Warnings and precautions
Talk to your doctor before taking Aprovel if you are in any of the following conditions:

    • excessive vomiting or diarrhoea
  • if you suffer from kidney problems
  • if you suffer from heart problems
  • if you are taking Aprovel for diabetic kidney disorders. In this case, your doctor may prescribe regular blood tests, especially to monitor serum potassium levels in case of poor kidney function
  • if you develop low blood sugar levels (symptoms may include sweating, weakness, hunger, dizziness, trembling, headache, flushing or pallor, numbness, rapid and pounding heartbeat), particularly if you are being treated for diabetes
    • if you are scheduled for surgery or are receiving anaesthetics
  • if you are taking any of the following medicines used to treat high blood pressure:
  • an "ACE inhibitor" (e.g. enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes
  • aliskiren
    Your doctor may regularly monitor your kidney function, blood pressure, and blood electrolyte levels (e.g. potassium).

See also the information under the heading "Do not take Aprovel".
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming pregnant). Aprovel is not recommended during early pregnancy and must not be taken after the third month of pregnancy, as it may cause serious harm to the unborn baby if taken during this period (see section Pregnancy).
Children and adolescents
This medicine should not be used in children and adolescents, as safety and efficacy have not yet been fully established.
Other medicines and Aprovel
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor may consider it necessary to adjust the dose and/or take additional precautions:
If you are taking an ACE inhibitor or aliskiren (see also the sections "Do not take Aprovel" and "Warnings and precautions").
You may need blood tests if you are taking:

  • potassium supplements
  • potassium-containing salt substitutes
  • potassium-sparing medicines (such as certain diuretics)
  • lithium-containing medicines
  • repaglinide (a medicine used to lower blood sugar levels)

If you are taking certain painkillers called non-steroidal anti-inflammatory drugs (NSAIDs), the effectiveness of irbesartan may be reduced.
Aprovel with food and drink
Aprovel can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You must inform your doctor if you think you may be pregnant (or if there is a possibility of becoming pregnant); your doctor will usually advise you to stop taking Aprovel before becoming pregnant or as soon as pregnancy is confirmed, and will recommend an alternative medicine. Aprovel is not recommended during early pregnancy and must not be taken after the third month of pregnancy, as it may cause serious harm to the unborn baby if taken beyond the third month of pregnancy.
Breast-feeding
Inform your doctor if you are breast-feeding or planning to breast-feed. Aprovel is not recommended for women who are breast-feeding, and your doctor may choose an alternative treatment if you wish to breast-feed, especially if the baby is a newborn or was born prematurely.
Driving and using machines:
It is unlikely that Aprovel will affect your ability to drive or use machinery. However, occasionally, dizziness or fatigue may occur during treatment for high blood pressure. If this happens, talk to your doctor before driving or operating machinery.
Aprovel contains lactose. If your doctor has diagnosed you with an intolerance to certain sugars, contact him before taking this medicine.
Aprovel contains sodium. This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e. it is essentially 'sodium-free'.

3. How to take Aprovel

Take this medicine exactly as your doctor has told you. If you are unsure, consult your doctor or pharmacist.
Method of administration
Aprovel is for oral use. Swallow the tablets with a sufficient amount of fluid (e.g.: a glass of water). You may take Aprovel with or without food. Try to take the medicine at the same time each day. Treatment should be continued for as long as your doctor considers it necessary.

  • Patients with high blood pressure: The usual dose is 150 mg once daily. The dose may subsequently be increased to 300 mg once daily, depending on the reduction in blood pressure levels.
  • Patients with high blood pressure and type 2 diabetes with kidney disease: In patients with high blood pressure and type 2 diabetes, the recommended maintenance dose is 300 mg once daily for the treatment of associated kidney disease.

Your doctor may decide to use lower doses, especially at the beginning of treatment, in particular patients such as those on haemodialysis, or in patients over 75 years of age.
Maximum antihypertensive effect should be achieved within 4–6 weeks after starting therapy.
Use in children and adolescents
Aprovel must not be given to children under 18 years of age. If a child ingests any tablets, contact your doctor immediately.
If you take more Aprovel than you should
If you accidentally take too many tablets, contact your doctor immediately.
If you forget to take Aprovel
If you accidentally miss a dose, continue with your next dose as usual. Do not take a double dose to make up for the forgotten dose.
If you have any doubts about how to use this medicine, consult your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some of these side effects can be serious and may require medical attention.
As with similar medicines, rare cases of skin allergic reactions (redness, rash, hives) as well as localized swelling of the face, lips and/or tongue have been reported in patients treated with irbesartan. If you experience any of these symptoms or have difficulty breathing, stop taking Aprovel and contact your doctor immediately.

The frequency of the side effects listed below is defined using the following convention:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people

Side effects reported in clinical studies in patients treated with Aprovel include:

  • Very common (may affect more than 1 in 10 people): if you have high blood pressure and type 2 diabetes with kidney disease, blood tests may show high levels of potassium.
  • Common (may affect up to 1 in 10 people): dizziness, feeling unwell/nausea, fatigue, and blood tests may show increased levels of an enzyme indicating muscle and heart function (creatine kinase). In patients with high blood pressure and type 2 diabetes with kidney disease, dizziness upon standing up from lying or sitting position, low blood pressure upon standing up from lying or sitting position, joint or muscle pain, and decreased levels of a protein in red blood cells (haemoglobin) have also been reported.
  • Uncommon (may affect up to 1 in 100 people): increased heart rate, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems related to sexual performance), chest pain.

Additional side effects have been reported since Aprovel has been marketed. Side effects with unknown frequency include: dizziness, headache, taste disturbances, ringing in the ears, muscle cramps, joint and muscle pain, reduced number of red blood cells (anaemia – symptoms may include tiredness, headache, shortness of breath during physical activity, dizziness and pale appearance), reduced platelet count, abnormal liver function, increased blood potassium levels, impaired kidney function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis), and severe allergic reactions (anaphylactic shock). Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, please inform your doctor or pharmacist.
You can also report side effects directly through the national reporting system listed in Annex V.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Aprorel

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after Exp.
The expiry date refers to the last day of the month.
Do not store above 30°C.
Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Aprovel contains

    • The active substance is irbesartan. Each Aprovel 300 mg tablet contains 300 mg of irbesartan.
    • The excipients are: monohydrate lactose, microcrystalline cellulose, cross-linked carmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3000, carnauba wax. See section 2 “Aprovel contains lactose”.

Description of the appearance of Aprovel and contents of the pack
Aprovel 300 mg film-coated tablets are white to almost white, biconvex, oval-shaped, with a heart engraved on one side and the number 2873 imprinted on the other side.
Aprovel 300 mg film-coated tablets are available in packs of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters. Single-dose blisters of 56 x 1 film-coated tablet are also available for hospital use.
Not all pack sizes may be marketed.

Marketing Authorisation Holder:
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France

Manufacturer:
SANOFI WINTHROP INDUSTRIE
1, rue de la Vierge
Ambarès & Lagrave
F-33565 Carbon Blanc Cedex - France
SANOFI WINTHROP INDUSTRIE
30-36 Avenue Gustave Eiffel, BP 7166
F-37071 Tours Cedex 2 - France
Sanofi-Aventis, S.A.
Ctra. C-35 (La Batlloria-Hostalric), km. 63.09
17404 Riells i Viabrea (Girona)
Spain

For further information on this medicinal product, please contact the local representative of the Marketing Authorisation Holder:

België/Belgique/Belgien Lietuva
Sanofi Belgium Swixx Biopharma UAB Tel: +370 5 236 91 40
Tél/Tel: +32 (0)2 710 54 00

България Luxembourg/Luxemburg
Swixx Biopharma EOOD Sanofi Belgium
Тел.: +359 (0)2 4942 480 Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)

Česká republika Magyarország
sanofi-aventis, s.r.o. SANOFI-AVENTIS Zrt.
Tel: +420 233 086 111 Tel.: +36 1 505 0050

Danmark Malta
Sanofi A/S Tel: +45 45 16 70 00 Sanofi S.r.l.
Tel: +39 02 39394275

Deutschland Nederland
Sanofi-Aventis Deutschland GmbH Genzyme Europe B.V.
Tel: 0800 52 52 010 Tel: +31 20 245 4000
Tel. aus dem Ausland: +49 69 305 21 131

Eesti Norge
Swixx Biopharma OÜ sanofi-aventis Norge AS
Tel: +372 640 10 30 Tlf: +47 67 10 71 00

Ελλάδα Österreich
Sanofi-Aventis Μονοπρόσωπη ΑΕΒΕ sanofi-aventis GmbH
Τηλ: +30 210 900 16 00 Tel: +43 1 80 185 – 0

España Polska
sanofi-aventis, S.A. sanofi-aventis Sp. z o.o.
Tel: +34 93 485 94 00 Tel.: +48 22 280 00 00

France Portugal
sanofi-aventis France Sanofi - Produtos Farmacêuticos, Lda
Tél: 0 800 222 555 Tel: +351 21 35 89 400
Appel depuis l’étranger : +33 1 57 63 23 23

Hrvatska România
Swixx Biopharma d.o.o. Sanofi Romania SRL
Tel: +385 1 2078 500 Tel: +40 (0) 21 317 31 36

Ireland Slovenija
sanofi-aventis Ireland Ltd. T/A SANOFI Swixx Biopharma d.o.o.
Tel: +353 (0) 1 403 56 00 Tel: +386 1 235 51 00

Ísland Slovenská republika
Vistor hf. Swixx Biopharma s.r.o.
Sími: +354 535 7000 Tel: +421 2 208 33 600

Italia Suomi/Finland
Sanofi S.r.l. Sanofi Oy
Tel: 800 536389 Puh/Tel: +358 (0) 201 200 300

Κύπρος Sverige
C.A. Papaellinas Ltd Sanofi AB
Τηλ: +357 22 741741 Tel: +46 (0)8 634 50 00

Latvija United Kingdom (Northern Ireland)
Swixx Biopharma SIA sanofi-aventis Ireland Ltd. T/A SANOFI
Tel: +371 6616 47 50 Tel: +44 (0) 800 035 2525

More detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu/